Search results
Bases follow-up testing on the difference between bilirubin level and the phototherapy threshold. No more risk zones! Raises thresholds for phototherapy and exchange transfusion. Includes gestational age and risk factors for neurotoxicity in the thresholds.
19 maj 2010 · This guideline covers diagnosing and treating jaundice, which is caused by increased levels of bilirubin in the blood, in newborn babies (neonates). It aims to help detect or prevent very high levels of bilirubin, which can be harmful if not treated.
Neonatal jaundice. Treatment threshold graphs. NICE clinical guideline 98. Developed by the National Collaborating Centre for Women’s and Children’s Health. These treatment threshold graphs accompany the clinical guideline: ‘Neonatal jaundice’. They are also available as an implementation tool.
Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.
When using this nomogram, remember that "risk" refers to the risk of a subsequent bilirubin level in that infant >95th percentile for age.
Neonatal Algorithm for Bilirubinometer use. Transcutaneous Bilirubin Measurement (TcB) Measures bilirubin of subcutaneous tissue and closely correlates with serum bilirubin. Measurement site: Sternum or forehead. Clinically Jaundiced. Do Not Use TCB. *Previous/current Phototherapy use <35 weeks <24 hours. > days. Please do SBR.
1 cze 2007 · Hyperbilirubinemia is very common and usually benign in the term newborn infant and the late preterm infant at 35 to 36 completed weeks’ gestation. Critical hyperbilirubinemia is uncommon but has the potential for causing long-term neurological impairment.
